Chairs

Chairs Scientific Sessions (in alphabetical order)

David Adams, Université Paris Saclay, Paris, France
Kerstin Amann, University Hospital, Erlangen, Germany
Vittorio Bellotti, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
Norbert Blank, Amyloidosis Center of the University Hospital, Heidelberg, German
Alexander Carpinteiro, Amyloidosis Center of the University Hospital, Essen, Germany
Maite Cibeira, Amyloidosis and Myeloma Unit, Barcelona, Spain
Thibaud Damy, Henri Mondor University Hospital, Créteil, France
Sharmila Dorbala, Brigham and Women’s Hospital, Boston, USA
Carlos Fernández de Larrea, Amyloidosis and Myeloma Unit, Barcelona, Spain
Sophie Georgin-Lavialle, Sorbonne University, Paris, France
Ute Hegenbart, host ISA 2022, Amyloidosis Center of the University Hospital, Heidelberg, Germany
Efstathios Kastritis, National and Kapodistrian University, Athens, Greece
Shaji Kumar, Mayo Clinic, Rochester, Minnesota, USA
Nelson Leung, Mayo Clinic, Rochester, USA
Matthew Maurer, Columbia University, New York, USA
Paolo Milani, Amyloidosis Research and Treatment Center, University of Pavia and IRCCS Fondazione Policlinico San Matteo, Pavia, Italy

Monique Minnema
, University Medical Center, Utrecht, Netherlands
Gareth Morgan, Amyloidosis Center at Boston University School of Medicine, Boston, USA
Hironobu Naiki, University of Fukui, Fukui, Japan
Giovanni Palladini, ISA president, Amyloidosis Research and Treatment Center, University of Pavia and IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
Marina Ramirez-Alvarado, Mayo Clinic, Rochester, USA
Stefano Ricagno, Università di Milano, Milano, Italy
Eloisa Riva, Hospital de Clínicas “Dr. Manuel Quintela”, Montevideo, Uruguay
Christoph Röcken, University Hospital, Kiel, Germany
Vaishali Sanchorawala, Amyloidosis Center at Boston University School of Medicine, Boston, USA
Matthias Schmidt, University Ulm, Ulm, Germany
Stefan Schönland, host ISA 2022, Amyloidosis Center of the University Hospital, Heidelberg, Germany
Fabian aus dem Siepen, Amyloidosis Center of the University Hospital, Heidelberg, Germany
Marcia Waddington-Cruz, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Ashutosh Wechalekar, National Amyloidosis Centre, London, United Kingdom
Gunilla Westermark, Uppsala University, Uppsala, Sweden

And ISA 2022 Organizing Committee

Chairs Poster Sessions

Poster Session Monday

AL amyloidosis

Vaishali Sanchorawala, Amyloidosis Center at Boston University School of Medicine, Boston, USA
Paolo Milani, Amyloid Research and Treatment Center, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
Maite Cibeira, Amyloidosis and Myeloma Unit, Barcelona, Spain
Timon Hansen, Haematology-Oncology Clinic, Altona, Hamburg, Germany
Hermine Agis, Department of Medicine, Medical University of Vienna, Vienna, Austria
Angela Dispenzieri, Mayo Clinic, Rochester, USA
Jeffrey Zonder, Karmanos Cancer Institute, Detroit, USA

ATTRwt amyloidosis

Thibaud Damy, Henri Mondor University Hospital, Créteil, France
Matthew Maurer, Columbia University, New York, USA
Pablo Garcia-Pavia, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
Maria Papathanasiou, University Hospital Essen, Germany

ATTRv amyloidosis

Marcia Waddington-Cruz, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Katrin Hahn, Amyloidosis Center, Charité, Berlin, Germany
Isabel Maria Conceicao, Centro Hospitalar Universitário Lisboa Norte – Hospital de Santa Maria, Lisboa, Portugal
Markus Weiler, Amyloidosis Center of the University Hospital, Heidelberg, Germany


Poster Session Tuesday

Fibril and Amyloid Formation

Mario Nuvolone, Amyloidosis Research and Treatment Center, University of Pavia and IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
Christoph Röcken, University Hospital, Kiel, Germany
Joost Schymkowitz, Leuven Center for Brain & Disease Research, Leuven, Belgium

Mechanism of organ dysfunction and damage

Marina Ramirez-Alvarado, Mayo Clinic, Rochester, USA
Stefano Ricagno, Università di Milano, Milano, Italy

Pre-clinical disease models

Gunilla Westermark, Uppsala University, Uppsala, Sweden
Alexander Carpinteiro, University Hospital Essen, Germany

Imaging

Simon Gibbs, The Victorian and Tasmanian Amyloidosis Service, Australian Amyloidosis Network, Australia
Jennifer Hayes, Amyloidosis Center of the University Hospital, Heidelberg, Germany
Jonathan Wall, University of Tennessee, Knoxville, USA
Martha Grogan, Mayo Clinic, Rochester, USA

Late Breaking Abstracts

Suzanne Lentzsch, Columbia University, New York, USA
Per Westermark, Uppsala University, Uppsala, Sweden

Poster Session Wednesday

Pathway to Diagnosis

Eli Muchtar, Mayo Clinic, Rochester, USA
Rahel Schwotzer, University Hospital, Zurich, Switzerland
Fabian aus dem Siepen, Amyloidosis Center of the University Hospital, Heidelberg, Germany
Eloisa Riva, Hospital de Clínicas “Dr. Manuel Quintela”, Montevideo, Uruguay
Sandra Ihne, Amyloidosis Center, University Hospital Würzburg, Germany
Hans Nienhuis, Amyloidosis Centre of Expertise, University Medical Center, Groningen, Netherlands
Kerstin Amann, University Hospital, Erlangen, Germany
Hironobu Naiki, University of Fukui, Fukui, Japan
Arnaud Jaccard, CHU, Limoges, France

AA Amyloidosis

Norbert Blank, Amyloidosis Center of the University Hospital, Heidelberg, Germany

Biology, Clinics and Therapeutics in other types of amyloidosis

Laura Obici, Amyloidosis Research and Treatment Center, University of Pavia and IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
Ernst Hund, Amyloidosis Center of the University Hospital, Heidelberg, Germany

Innovative Therapies

Efstathios Kastritis, National and Kapodistrian University, Athens, Greece
Gareth Morgan, Amyloidosis Center at Boston University School of Medicine, Boston, USA
Peter Mollee, Princess Alexandra Hospital, Brisbane, Queensland, Australia